AAAAAA

   
Results: 1-18 |
Results: 18
Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-1 with severe hypercholesterolaemia
Authors: Boullier, A Hennuyer, N Tailleux, A Furman, C Duverger, N Caillaud, JM Castro, G Fievet, C Fruchart, JC Duriez, P
Citation: A. Boullier et al., Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-1 with severe hypercholesterolaemia, CLIN SCI, 100(3), 2001, pp. 343-355
Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor
Authors: Claudel, T Leibowitz, MD Fievet, C Tailleux, A Wagner, B Repa, JJ Torpier, G Lobaccaro, JM Paterniti, JR Mangelsdorf, DJ Heyman, RA Auwerx, J
Citation: T. Claudel et al., Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor, P NAS US, 98(5), 2001, pp. 2610-2615
Metabolic effects of rexinoids: Tissue-specific regulation of lipoprotein lipase activity
Authors: Davies, PJA Berry, SA Shipley, GL Eckel, RH Hennuyer, N Crombie, DL Ogilvie, KM Peinado-Onsurbe, J Fievet, C Leibowitz, MD Heyman, RA Auwerx, J
Citation: Pja. Davies et al., Metabolic effects of rexinoids: Tissue-specific regulation of lipoprotein lipase activity, MOLEC PHARM, 59(2), 2001, pp. 170-176
Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11 beta-hydroxysteroid dehydrogenase type 1 null mice.
Authors: Morton, NM Holmes, MC Fievet, C Staels, B Tailleux, A Mullins, JJ Seckl, JR
Citation: Nm. Morton et al., Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11 beta-hydroxysteroid dehydrogenase type 1 null mice., J BIOL CHEM, 276(44), 2001, pp. 41293-41300
Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity - Studies with congenic mouse lines
Authors: Akiyama, TE Nicol, CJ Fievet, C Staels, B Ward, JM Auwerx, J Lee, SST Gonzalez, FJ Peters, JM
Citation: Te. Akiyama et al., Peroxisome proliferator-activated receptor-alpha regulates lipid homeostasis, but is not associated with obesity - Studies with congenic mouse lines, J BIOL CHEM, 276(42), 2001, pp. 39088-39093
Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor ROR alpha
Authors: Raspe, E Duez, H Gervois, P Fievet, C Fruchart, JC Besnard, S Mariani, J Tedgui, A Staels, B
Citation: E. Raspe et al., Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor ROR alpha, J BIOL CHEM, 276(4), 2001, pp. 2865-2871
Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1
Authors: Singaraja, RR Bocher, V James, ER Clee, SM Zhang, LH Leavitt, BR Tan, B Brooks-Wilson, A Kwok, A Bissada, N Yang, YZ Liu, GQ Tafuri, SR Fievet, C Wellington, CL Staels, B Hayden, MR
Citation: Rr. Singaraja et al., Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and apoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1, J BIOL CHEM, 276(36), 2001, pp. 33969-33979
Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate
Authors: Bouly, M Masson, D Gross, B Jiang, XC Fievet, C Castro, G Tall, AR Fruchart, JC Staels, B Lagrost, L Luc, G
Citation: M. Bouly et al., Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate, J BIOL CHEM, 276(28), 2001, pp. 25841-25847
Measurement of rabbit apolipoprotein B by use of electroimmunodiffusion and immunonephelometric assays
Authors: Tailleux, A Labbe, J Mallet, C Percevault, F Fruchart, JC Fievet, C
Citation: A. Tailleux et al., Measurement of rabbit apolipoprotein B by use of electroimmunodiffusion and immunonephelometric assays, COMPAR MED, 50(3), 2000, pp. 309-313
Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice
Authors: Tailleux, A Bouly, M Luc, G Castro, G Caillaud, JM Hennuyer, N Poulain, P Fruchart, JC Duverger, N Fievet, C
Citation: A. Tailleux et al., Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice, ART THROM V, 20(11), 2000, pp. 2453-2458
Activation of PPAR delta alters lipid metabolism in db/db mice
Authors: Leibowitz, MD Fievet, C Hennuyer, N Peinado-Onsurbe, J Duez, H Berger, J Cullinan, CA Sparrow, CP Baffic, J Berger, GD Santini, C Marquis, RW Tolman, RL Smith, RG Moller, DE Auwerx, J
Citation: Md. Leibowitz et al., Activation of PPAR delta alters lipid metabolism in db/db mice, FEBS LETTER, 473(3), 2000, pp. 333-336
Loss of atheroprotective effect of estradiol in immunodeficient mice.
Authors: Elhage, R Clamens, S Reardon-Alulis, C Getz, GS Fievet, C Maret, A Arnal, JF Bayard, F
Citation: R. Elhage et al., Loss of atheroprotective effect of estradiol in immunodeficient mice., ENDOCRINOL, 141(1), 2000, pp. 462-465
Study of the arc-electrode interaction in a SF6 self-blast circuit breaker
Authors: Chevrier, P Fievet, C Ciobanu, SS Fleurier, C Scarpa, P
Citation: P. Chevrier et al., Study of the arc-electrode interaction in a SF6 self-blast circuit breaker, J PHYS D, 32(13), 1999, pp. 1494-1502
Coupling between physical arc modelling and circuit modelling in a circuit-breaker
Authors: Verite, JC Boucher, T Comte, A Barrault, M Chevrier, P Fievet, C
Citation: Jc. Verite et al., Coupling between physical arc modelling and circuit modelling in a circuit-breaker, IEEE MAGNET, 35(3), 1999, pp. 1614-1617
3-hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase
Authors: Schoonjans, K Peinado-Onsurbe, J Fruchart, JC Tailleux, A Fievet, C Auwerx, J
Citation: K. Schoonjans et al., 3-hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase, FEBS LETTER, 452(3), 1999, pp. 160-164
Protective role of interleukin-10 in atherosclerosis
Authors: Mallat, Z Besnard, S Duriez, M Deleuze, V Emmanuel, F Bureau, MF Soubrier, F Esposito, B Duez, H Fievet, C Staels, B Duverger, N Scherman, D Tedgui, A
Citation: Z. Mallat et al., Protective role of interleukin-10 in atherosclerosis, CIRCUL RES, 85(8), 1999, pp. E17-E24
Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response
Authors: Hennuyer, N Poulain, P Madsen, L Berge, RK Houdebine, LM Branellec, D Fruchart, JC Fievet, C Duverger, N Staels, B
Citation: N. Hennuyer et al., Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response, CIRCULATION, 99(18), 1999, pp. 2445-2451
Branched synthetic peptide constructs mimic cellular binding and efflux ofapolipoprotein AI in reconstituted high density lipoproteins
Authors: Nion, S Demoor, L Boutillon, C Luchoomun, J Vanloo, B Fievet, C Castro, G Rosseneu, M Fruchart, JC Tartar, A Clavey, V
Citation: S. Nion et al., Branched synthetic peptide constructs mimic cellular binding and efflux ofapolipoprotein AI in reconstituted high density lipoproteins, ATHEROSCLER, 141(2), 1998, pp. 227-235
Risultati: 1-18 |